Brokerages Set DRI Healthcare Trust (TSE:DHT.UN) Target Price at C$18.25

DRI Healthcare Trust (TSE:DHT.UN) has earned a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1 year price target among brokers that have updated their coverage on the stock in the last year is C$18.25.

DHT.UN has been the topic of a number of research analyst reports. Truist Financial dropped their price target on DRI Healthcare Trust from C$17.00 to C$14.00 in a research note on Thursday, July 25th. National Bankshares cut their price target on shares of DRI Healthcare Trust from C$23.50 to C$17.50 and set an “outperform” rating on the stock in a research note on Tuesday, July 9th. Stifel Nicolaus cut shares of DRI Healthcare Trust from a “buy” rating to a “hold” rating and decreased their price target for the stock from C$22.00 to C$15.00 in a report on Tuesday, July 9th. CIBC dropped their price objective on shares of DRI Healthcare Trust from C$20.00 to C$18.50 in a report on Tuesday, July 9th. Finally, Royal Bank of Canada reduced their target price on DRI Healthcare Trust from C$20.00 to C$16.00 in a research note on Tuesday, July 9th.

DRI Healthcare Trust Stock Performance

Shares of DHT.UN stock opened at C$14.11 on Wednesday. The stock’s fifty day moving average price is C$12.66 and its 200 day moving average price is C$14.06. DRI Healthcare Trust has a 1-year low of C$10.39 and a 1-year high of C$17.43.

DRI Healthcare Trust Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 18th. Investors of record on Friday, October 18th will be given a dividend of $0.085 per share. The ex-dividend date is Friday, September 27th. This represents a $0.34 dividend on an annualized basis and a yield of 2.41%. DRI Healthcare Trust’s dividend payout ratio is presently -920.00%.

DRI Healthcare Trust Company Profile

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.